SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-098942
Filing Date
2020-04-06
Accepted
2020-04-06 08:02:06
Documents
4
Period of Report
2020-04-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d831424d8k.htm 8-K 32683
2 EX-99.1 d831424dex991.htm EX-99.1 22754
3 GRAPHIC g831424831424graphics.jpg GRAPHIC 9060
4 GRAPHIC g831424g0406093211041.jpg GRAPHIC 2501
  Complete submission text file 0001193125-20-098942.txt   72806
Mailing Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 499 ILLINOIS STREET SUITE 500 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 20775779
SIC: 2836 Biological Products, (No Diagnostic Substances)